Recall of Solcoseryl Eye Gel (with photo)

     The Department of Health (DH) today (October 7) endorsed a licensed drug wholesaler, A Menarini Hong Kong Limited (A Menarini), to recall Solcoseryl Eye Gel (Hong Kong Registration Number: HK-21628), from the market as a precautionary measure because the sterility of the product cannot be guaranteed.

     The DH received notification from overseas health authorities that the manufacturer of the product failed to comply with the Good Manufacturing Practice in their sterile manufacturing operations, and the sterility of their sterile medicinal products cannot be guaranteed. As a precautionary measure, A Menarini voluntarily recalled the product from the market.

     The above product, containing calf blood derivatives, is used for the treatment of disorders or injuries of the cornea or conjunctiva of the eye. According to the wholesaler, the product has been supplied to the Hospital Authority, the DH, private hospitals, local private doctors, pharmacies and medicine stores.

     A Menarini has set up a hotline (3605 5831) to answer related enquiries.

     "So far, the DH has not received any adverse reaction reports in connection with the product, and will closely monitor the recall," a spokesman for the DH said.

     "Patients who are using the above product should stop using it, and should seek advice from their healthcare professionals as soon as possible for appropriate arrangements," the spokesman added.